IL17A and escherichia coli infection: The beneficial roles of IL-17A have been demonstrated in mice in the context of BCG vaccination [39], pneumococcal infection in humans [40], Mycoplasma hyopneumoniae infection in swine [41], and enterotoxigenic E. coli infection and oral immunization with F4 fimbriae in swine [42].